Life Extension Magazine December 2004
Can Curcumin Prevent Alzheimer's Disease?
By John C. Martin
By John C. Martin
|LE Magazine December 2004|
|Can Curcumin Prevent Alzheimer's Disease?|
By John C. Martin
Curcumin has long been prized in traditional Chinese and Indian medicine as a natural remedy for a variety of ailments. In modern research laboratories, curcumin’s ability to scavenge free radicals and suppress inflammatory cytokines has impressed scientists who are seeking ways to prevent and treat Alzheimer’s disease and other neurodegenerative disorders.
Alzheimer’s disease was discovered in 1907 by Dr. Alois Alzheimer, a German medical researcher who described a unique and destructive pathology in his patients’ brains.1 Today as then, Alzheimer’s is a ravaging illness that robs its victims not only of their health, but also of their relationships with family and friends. Alzheimer’s is also a burgeoning disease that affects more than 4 million Americans, a number that has doubled in the past 25 years. The disease is expected to continue its devastating surge over the next several decades.2
No cure exists for Alzheimer’s, and the drugs currently available to treat the disease address only its symptoms, and with only limited effectiveness. Medical experts believe that therapeutic intervention that could postpone the onset or progression of Alzheimer’s—even by as little as two years—would dramatically reduce the number of cases over the next 50 years.3 A growing body of evidence suggests that a promising therapeutic modality may already be available. This remedy is most commonly found not in a biochemical laboratory, but rather in the kitchen spice rack: the perennial herb known around the world as turmeric.
From Ancient Healing to Modern Medicine
In addition to its uses as a spice, turmeric has been used therapeutically over the centuries in different parts of the world. Turmeric is rich in its active compound, curcumin, which is widely prescribed in Indian medicine as a potent remedy for liver disorders, rheumatism, diabetic wounds, runny nose, cough, and sinusitis.5 Traditional Chinese medicine uses curcumin as a treatment for diseases associated with abdominal pain, and it is used in ancient Hindu medicine as a treatment for sprains and swelling.5
While the therapeutic use of this treasured spice has been commonplace throughout history, emerging medical research has begun to elucidate curcumin’s beneficial effects for a range of diseases and conditions. Much of the recent science has focused on its effects against cancer, both therapeutically and prophylactically.6 Curcumin’s potential apparently stems from its ability to suppress the proliferation of a wide variety of tumor cells and to inhibit harmful molecules and enzymes, as well as its antioxidant and anti-inflammatory properties. Some studies have even suggested that curcumin can inhibit cancer metastasis.6
In research studies, curcumin has shown potential activity against cataract formation,7 liver injury,8 and the resultant damage from heart attack9 and stroke.10 More important, curcumin’s anti-inflammatory effects and apparent effectiveness in keeping Alzheimer’s disease at bay are attracting the notice of more and more medical researchers.
Alzheimer’s and Its Risk Factors
Alzheimer’s disease primarily involves the parts of the brain that control thought, memory, and language. Its causes are still essentially unknown, and no cure exists. Alzheimer’s evolves slowly. At first, its only symptom may be mild forgetfulness. As the disease progresses, more serious symptoms arise, such as forgetting how to carry out simple tasks like combing one’s hair or brushing one’s teeth. People with Alzheimer’s disease eventually require comprehensive care.11
There is probably no one specific cause of Alzheimer’s disease; instead, several factors are likely to affect each person differently. Age is a common denominator in the disease, with the incidence of Alzheimer’s doubling every five years in people over age 65. Family history also plays an important role, as Alzheimer’s disease with a familial component can occur between the ages of 30 and 60. In older people, however, no obvious family pattern has been noted.11 Other genes that may be centrally involved in the onset and progression of Alzheimer’s remain to be discovered.
One recently discovered risk factor is the presence of a protein known as apolipoprotein E, which normally helps carry cholesterol in the blood. This molecule has three forms, and while one form helps protect people from Alzheimer’s disease, scientists have found another form that can do just the opposite.12
Alzheimer’s disease is characterized by two key abnormalities in the brain: amyloid plaques and neurofibrillary tangles. Amyloid plaques are clumps of a protein known as beta amyloid. They are found in the tissue between nerve cells in the brain, along with degenerating bits of neurons and other cells.13
Neurofibrillary tangles, largely comprising a protein called tau, are bundles of twisted filaments found within neurons. In healthy individuals, the tau protein augments the function of microtubules (part of the cell’s structural support) and delivers various substances throughout them. In Alzheimer’s sufferers, tau’s function is transformed abnormally so that it twists into pairs of helical filaments that collect in tangles. When this occurs, the microtubules do not function correctly and disintegrate. The resulting collapse of the neurons’ transport system eventually impairs communication between nerve cells, and causes them to die.13
Targeting Destructive Plaques and Cells
In another in-vitro study, researchers studied the action of curcumin against the abnormal growth and proliferation of neuroglial cells, which provide mechanical and physical support for, as well as electrical insulation between, neurons in the brain.15 In Alzheimer’s disease, a condition known as gliosis can occur, characterized by the rapid proliferation of neuroglia. Alzheimer’s disease is also marked by astrocytosis, an abnormal proliferation of astrocytes near neurodegenerative lesions. Astrocytes are the largest and most numerous neuroglial cells in the central nervous system.
In this study, researchers at the University of California, Berkeley, infused various doses of curcumin into rat glioma cells, which are malignant tumors of neuroglial origin. The researchers concluded: “Curcumin inhibited neuroglial proliferation, with the degree of inhibition correlated directly with the curcumin concentration.”15
Amyloid plaques are known to cause oxidative damage in the brains of Alzheimer’s sufferers. Free radicals generated by beta amyloid and other factors, such as mitochondrial abnormalities in cells, inadequate energy supply, inflammation, or abnormal changes in natural antioxidant defenses, may play a role in the pathophysiology of Alzheimer’s disease. Substances with antioxidant properties, such as curcumin, may therefore offer biochemical support in this condition.
“Treatment with antioxidants is a promising approach for slowing disease progression to the extent that oxidative damage may be responsible for the cognitive and functional decline observed in Alzheimer’s disease,” wrote researchers at the University of California, San Diego.16
In another theory of how curcumin provides its advantageous effects against oxidative damage, medical experts speculate that curcumin induces a heat-shock response in the brain.17 Heat-shock proteins serve as a prophylaxis against stress exerted on cells.
Impressive Pre-clinical Research Evidence
In a pre-clinical trial involving 22 rodents, researchers gave the rats a beta amyloid amino acid, which resulted in oxidative damage, loss of synaptophysin (a protein involved in brain synapses), and widespread amyloid deposits. When both ibuprofen and curcumin were then introduced into the rats’ diets after this cerebral damage had occurred, only curcumin suppressed both the oxidative damage and continual synaptophysin loss.18 Both interventions reduced levels of microglia—small glial cells in that brain that serve as support structures for neurons—in the cortical layers.18
In a second group of rats infused with beta amyloid, dietary curcumin prevented spatial memory problems as shown in the Morris Water Maze exercise, a sensitive test used to assess spatial memory, in which rats must locate a hidden escape platform. These rats also showed lower levels of beta amyloid after curcumin was introduced in their diet. “Because of its low side-effect profile and long history of safe use, curcumin may find clinical application for Alzheimer’s disease prevention,” the study team concluded.18
Additional pre-clinical studies echo these findings.21 In a 2001 study, UCLA researchers fed groups of mice one of two different doses of curcumin (160 or 5,000 parts per million) as part of their normal diet. The researchers wanted to determine how each dose affected inflammation, oxidative damage, and cerebral plaque levels. Both doses of the spice were effective. Curcumin lowered levels of oxidized proteins and the proinflammatory cytokine known as interleukin-1 beta, which were previously elevated in the brains of the mice. Interestingly, only low-dose curcumin lowered levels of an inflammatory biological marker, glial fibrillary acidic protein, by as much as 16%. Amyloid plaques were also reduced in the rodents’ brains by up to 50%. Microgliosis was also suppressed when rats were fed curcumin, though only in neuronal layers and not in proximity to plaques.21
The researchers concluded that curcumin “is a promising agent” as a prophylactic therapy against Alzheimer’s and possibly other brain disorders such as Parkinson’s disease.21